News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cunningham Ann Michelle
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2020 |
4
| Cunningham Ann Michelle (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.398, valued at
$29.9k
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Cunningham Ann Michelle (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1, valued at
$50k
|
|
| 01/14/2019 |
4
| Cunningham Ann Michelle (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.74, valued at
$43.5k
|
|
| 01/14/2019 |
3
| Cunningham Ann Michelle (Director) has filed a Form 3 on VistaGen Therapeutics, Inc. |
|
|